Oral and Poster Abstracts
Oral and Poster Abstracts
Oral and Poster Abstracts
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3 Canadian Food Inspection Agency, Epidemiology <strong>and</strong> Surveillance<br />
Section, Ottawa, Canada<br />
Bovine Spongiform Encephalopathy (BSE) was first diagnosed in<br />
Canada in 1993, in a cow imported from the United Kingdom. In 2003,<br />
the first indigenous case of BSE was diagnosed. To the end of 2007, a<br />
total of 12 indigenous cases of BSE had been diagnosed in cattle born<br />
in Western Canada. From the time Canada made BSE reportable in<br />
1990, surveillance has evolved from passive to active, with a markedly<br />
greater intensity following the discovery of the first indigenous case.<br />
To assess Canada’s true prevalence of BSE <strong>and</strong> the effectiveness of its<br />
surveillance, a retrospective study was designed based on the r<strong>and</strong>om<br />
selection of 3,712 samples from the 95,383 cattle brain samples<br />
submitted for BSE testing between 1992 <strong>and</strong> 2005. The sampling plan<br />
was based on an a priori estimation of the proportional distribution of<br />
National, Western <strong>and</strong> Eastern BSE surveillance samples by Office<br />
International des Epizooties (OIE) surveillance stream (clinical<br />
suspect, casualty slaughter, fallen stock, <strong>and</strong> routine slaughter). For<br />
each sample, data was obtained by record tracing <strong>and</strong> interviewing of<br />
identifiable current <strong>and</strong> original owners. Information recorded<br />
comprised sampling site <strong>and</strong> date, age of the animal, date of birth,<br />
breed, production type, province of sampling, province of birth, clinical<br />
signs preceding <strong>and</strong> reason for death, diagnostic test used <strong>and</strong> test<br />
result. Each sample was classified by OIE surveillance stream.<br />
Analyses on a National, Western <strong>and</strong> Eastern basis highlighted regional<br />
variability among surveillance strategies. Reflecting underlying<br />
population demographics <strong>and</strong> market flows, Eastern Canadian<br />
surveillance emphasized deadstock/renderer sampling (70.5%) while<br />
surveillance in Western Canada focused on on-farm sampling (84.1%).<br />
Sampling in Western Canada was predominantly from beef cattle<br />
(78.3%), with a mean age at sampling of 8.1 years. In Eastern Canada,<br />
the majority of samples originated from dairy cattle (84%), with a mean<br />
age at sampling of 4.7 years. The majority of samples examined were<br />
classified as casualty slaughter (63.7% in Eastern Canada <strong>and</strong> 80.4% in<br />
Western Canada). National, Eastern Canada <strong>and</strong> Western Canada<br />
prevalence estimates were determined. Results of the study have<br />
contributed to a broader assessment of the natural history of BSE in<br />
North America.<br />
86 Pregsure Trivalent Induces Much Higher Neutralising<br />
Antibody Titres against BVDV-2 Strains than Monovalent<br />
BVD Vaccines<br />
R. Raue, D. Hurst, J. Salt<br />
Pfizer Animal Health, R&D, S<strong>and</strong>wich, United Kingdom<br />
Objectives: Bovine viral diarrhoea virus (BVDV) is one of the most<br />
common <strong>and</strong> economically important viruses causing infections in<br />
cattle. Recently, severe outbreaks of BVDV-2 have been described in<br />
the UK. In addition, isolation of BVDV-2 has been reported in most<br />
European countries. As vaccination against BVDV is most often<br />
performed with inactivated vaccines, neutralising antibodies can be a<br />
good in vitro indicator of the ability to protect against a certain BVDV<br />
strain or type. This study was designed to compare the neutralisation<br />
antibody titres induced after vaccination with a novel vaccine PregSure<br />
Trivalent (Pfizer Animal Health), Bovilis BVD (Intervet) <strong>and</strong> Bovidec<br />
(Novartis Animal Health) against a panel of BVDV-1 <strong>and</strong> 2 strains.<br />
Materials <strong>and</strong> Method: Serum samples were collected from calves 3<br />
weeks after vaccination either with PregSure Trivalent, Bovilis BVD or<br />
Bovidec according to the recommendations of the manufacturer. They<br />
were tested in a serum neutralisation test against 11 BVDV-1 strains,<br />
representing genotypes 1a, 1b <strong>and</strong> 1d to 1i, as well as 4 BVDV-2 strains<br />
from Europe <strong>and</strong> the US.<br />
Results: The geometric mean titre in log2 for the 11 BVDV-1 strains<br />
were between 7.3 <strong>and</strong> 10.8 for PregSure Trivalent, 5.7 <strong>and</strong> 9.5 for<br />
Bovilis BVD <strong>and</strong> 4.0 <strong>and</strong> 8.2 for Bovidec. With all vaccine sera<br />
BVDV-1h strain G-AU was neutralised best <strong>and</strong> BVDV-1d strain<br />
PI810 worst. The geometric mean titre in log2 for the 4 BVDV-2<br />
strains where between 8.5 <strong>and</strong> 10.1 for PregSure Trivalent, 1.9 <strong>and</strong> 5.1<br />
for Bovilis BVD <strong>and</strong> 1.2 <strong>and</strong> 2.2 for Bovidec. Therefore, PregSure<br />
Trivalent serum samples showed an equal ability to neutralise BVDV-<br />
1 <strong>and</strong> 2 strains whereas Bovilis BVD <strong>and</strong> Bovidec serum samples<br />
showed a reduction in the ability to neutralise BVDV-2 strains by at<br />
least 4 log2. In some cases Bovilis BVD <strong>and</strong> Bovidec vaccine sera were<br />
not able to neutralise BVDV-2 strains at all.<br />
Conclusions: The results of this study demonstrate that the level of<br />
neutralising antibodies after vaccination with PregSure Trivalent is<br />
remarkably higher against BVDV-2 strains than those of monovalent<br />
inactivated BVD vaccines. In combination with the demonstration of<br />
12 month protection against BVDV-1 <strong>and</strong> 2 by challenge, this data<br />
indicate that the novel vaccine PregSure Trivalent gives a<br />
comprehensive cover against all types of BVDV field infections.<br />
Key words: PregSure Trivalent, BVDV-1, BVDV-2, neutralisation<br />
87 Monitoring of a BVDV Infection in a Vaccinated Herd by<br />
Testing of Milk for Antibodies against NS3<br />
B. Makoschey 1 , H. Kuijk 2 , J. Mars 3 , W. bij de Weg 2 , P. Franken 3<br />
1<br />
Intervet-Schering Plough, Int. Marketing, Boxmeer, Netherl<strong>and</strong>s<br />
2<br />
Intervet-Schering Plough, Intervet Netherl<strong>and</strong>s, Boxmeer,<br />
Netherl<strong>and</strong>s<br />
3<br />
Animal Health Service Deventer, Deventer, Netherl<strong>and</strong>s<br />
Objectives: It has been demonstrated earlier, that an inactivated<br />
vaccine against the bovine viral diarrhoea virus (BVDV) in<br />
combination with a suitable test for antibodies against non structural<br />
proteins (NS) exhibits properties of a marker vaccine: animals usually<br />
remain seronegative after vaccination but develop NS specific<br />
antibodies after field virus infection. In this study, it should be<br />
established, whether the NS3 antibody testing of individual or bulk<br />
milk samples is likewise suitable for differentiation between BVDV<br />
vaccinated <strong>and</strong> field virus infected animals.<br />
Materials <strong>and</strong> Methods: The study was performed on a Dutch dairy<br />
farm. After being certified as BVDV-virus-free in 2002, the farm<br />
experienced a new outbreak of BVDV in 2005. A herd vaccination<br />
program was initiated using an inactivated BVDV vaccine (Bovilis R<br />
BVD, Intervet International). Seventeen cows were selected for further<br />
follow up: blood samples, individual milk samples <strong>and</strong> bulk milk<br />
samples were collected at pre-set time points. BVDV neutralizing<br />
antibody titers were measured <strong>and</strong> the NS3 antibody response was<br />
measured in a commercial ELISA test (Cedi-testR BVDV, Cedi<br />
Diagnostics, Lelystad, The Netherl<strong>and</strong>s).<br />
Results: All animals that were seronegative before vaccination<br />
developed BVDV neutralizing antibodies after immunization. Three of<br />
the ten vaccinated animals showed an increase in the titers of BVDV<br />
neutralising antibodies, between study days 56 <strong>and</strong> 210, indicating that<br />
they experienced a field virus infection. All samples from animals that<br />
were vaccinated but not infected were tested negative for NS3 specific<br />
antibodies at all time points. The samples from the three animals that<br />
were infected after the vaccination were tested negative for NS3<br />
specific antibodies at Day 0, 28 <strong>and</strong> 56, but were positive thereafter. In<br />
contrast, all serum samples taken from animals that have been infected<br />
with BVDV field virus were tested positive for NS3 specific antibodies.<br />
The overall majority (37/44) of the milk samples for these animals were<br />
also tested positive in the NS3 ELISA. Likewise, the bulk milk samples<br />
were positive in the NS3 ELISA, with the exception of the sample<br />
taken at study day 28.<br />
Conclusions: The results obtained demonstrate that a field virus<br />
infection with BVDV can be monitored by measurement of NS<br />
antibodies in blood or (bulk) milk samples, even in a vaccinated herd.<br />
88 Transmission of Bovine Viral Diarrhoea Virus (BVDV) from<br />
Persistently Infected Calves to Naive in-contact Cattle is Very<br />
Rapid <strong>and</strong> Efficient<br />
B. Makoschey 1 , M. Janssen 2<br />
1 Intervet-Schering-Plough, Int. Marketing, Boxmeer, Netherl<strong>and</strong>s<br />
2 Intervet-Schering Plough, R&D, Boxmeer, Netherl<strong>and</strong>s<br />
Objectives: The transmission of bovine viral diarrhoea virus (BVDV)<br />
from persistently infected (PI) calves to in-contact animals is generally<br />
considered to happen very efficiently. It should be determined, whether<br />
naive animals housed in adjacent pens to a PI are readily infected or<br />
whether housing in the same pen is required for efficient infection.<br />
Materials <strong>and</strong> Methods: Four heifers at the age of 10 months or older,<br />
negative for antibodies against BVDV, <strong>and</strong> free of BVDV <strong>and</strong> one three<br />
months old PI calf were included in the study. The heifers were housed as<br />
one group in a pen. The PI calf was housed in an adjacent pen. The animals<br />
were allowed to have direct contact through the fence. Blood samples were<br />
taken weekly <strong>and</strong> BVDV neutralising antibodies were determined.<br />
Results: All four heifers seroconverted within four weeks after<br />
introduction of the PI calf. These results, indicate that the infection with<br />
BVDV had occurred during the first week after the first contacts with<br />
the PI animal.<br />
Infectious <strong>and</strong> Zoonotic Deseases (Public Health) 77